UniProt ID | TERA_HUMAN | |
---|---|---|
UniProt AC | P55072 | |
Protein Name | Transitional endoplasmic reticulum ATPase | |
Gene Name | VCP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 806 | |
Subcellular Localization | Cytoplasm, cytosol . Endoplasmic reticulum . Nucleus . Present in the neuronal hyaline inclusion bodies specifically found in motor neurons from amyotrophic lateral sclerosis patients (PubMed:15456787). Present in the Lewy bodies specifically found i | |
Protein Description | Necessary for the fragmentation of Golgi stacks during mitosis and for their reassembly after mitosis. Involved in the formation of the transitional endoplasmic reticulum (tER). The transfer of membranes from the endoplasmic reticulum to the Golgi apparatus occurs via 50-70 nm transition vesicles which derive from part-rough, part-smooth transitional elements of the endoplasmic reticulum (tER). Vesicle budding from the tER is an ATP-dependent process. The ternary complex containing UFD1, VCP and NPLOC4 binds ubiquitinated proteins and is necessary for the export of misfolded proteins from the ER to the cytoplasm, where they are degraded by the proteasome. The NPLOC4-UFD1-VCP complex regulates spindle disassembly at the end of mitosis and is necessary for the formation of a closed nuclear envelope. Regulates E3 ubiquitin-protein ligase activity of RNF19A. Component of the VCP/p97-AMFR/gp78 complex that participates in the final step of the sterol-mediated ubiquitination and endoplasmic reticulum-associated degradation (ERAD) of HMGCR. Involved in endoplasmic reticulum stress-induced pre-emptive quality control, a mechanism that selectively attenuates the translocation of newly synthesized proteins into the endoplasmic reticulum and reroutes them to the cytosol for proteasomal degradation. [PubMed: 26565908 Also involved in DNA damage response: recruited to double-strand breaks (DSBs) sites in a RNF8- and RNF168-dependent manner and promotes the recruitment of TP53BP1 at DNA damage sites] | |
Protein Sequence | MASGADSKGDDLSTAILKQKNRPNRLIVDEAINEDNSVVSLSQPKMDELQLFRGDTVLLKGKKRREAVCIVLSDDTCSDEKIRMNRVVRNNLRVRLGDVISIQPCPDVKYGKRIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRKGDIFLVRGGMRAVEFKVVETDPSPYCIVAPDTVIHCEGEPIKREDEEESLNEVGYDDIGGCRKQLAQIKEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMSKLAGESESNLRKAFEEAEKNAPAIIFIDELDAIAPKREKTHGEVERRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEILQIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMDLIDLEDETIDAEVMNSLAVTMDDFRWALSQSNPSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIKGPELLTMWFGESEANVREIFDKARQAAPCVLFFDELDSIAKARGGNIGDGGGAADRVINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKANLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRRERERQTNPSAMEVEEDDPVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQSRGFGSFRFPSGNQGGAGPSQGSGGGTGGSVYTEDNDDDLYG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MASGADSKG ------CCCCCCCCC | 19.37 | 21406692 | |
3 | Phosphorylation | -----MASGADSKGD -----CCCCCCCCCC | 32.96 | 23401153 | |
7 | Phosphorylation | -MASGADSKGDDLST -CCCCCCCCCCCHHH | 37.69 | 25159151 | |
8 | Sumoylation | MASGADSKGDDLSTA CCCCCCCCCCCHHHH | 67.89 | - | |
8 | Acetylation | MASGADSKGDDLSTA CCCCCCCCCCCHHHH | 67.89 | 19335618 | |
8 | Sumoylation | MASGADSKGDDLSTA CCCCCCCCCCCHHHH | 67.89 | 28112733 | |
8 | Ubiquitination | MASGADSKGDDLSTA CCCCCCCCCCCHHHH | 67.89 | 21890473 | |
13 | Phosphorylation | DSKGDDLSTAILKQK CCCCCCHHHHHHHCC | 23.84 | 29255136 | |
14 | Phosphorylation | SKGDDLSTAILKQKN CCCCCHHHHHHHCCC | 25.64 | 29255136 | |
18 | Acetylation | DLSTAILKQKNRPNR CHHHHHHHCCCCCCC | 53.78 | 19335618 | |
18 | Sumoylation | DLSTAILKQKNRPNR CHHHHHHHCCCCCCC | 53.78 | 28112733 | |
18 | Ubiquitination | DLSTAILKQKNRPNR CHHHHHHHCCCCCCC | 53.78 | 21906983 | |
20 | Ubiquitination | STAILKQKNRPNRLI HHHHHHCCCCCCCEE | 54.02 | - | |
37 | Phosphorylation | EAINEDNSVVSLSQP ECCCCCCCEEECCCC | 35.90 | 22817900 | |
40 | Phosphorylation | NEDNSVVSLSQPKMD CCCCCEEECCCCCCC | 21.83 | 21712546 | |
45 | Ubiquitination | VVSLSQPKMDELQLF EEECCCCCCCCCHHH | 51.88 | 21906983 | |
46 | Sulfoxidation | VSLSQPKMDELQLFR EECCCCCCCCCHHHC | 6.52 | 21406390 | |
56 | Phosphorylation | LQLFRGDTVLLKGKK CHHHCCCEEEECCCC | 18.84 | 22817900 | |
60 | Sumoylation | RGDTVLLKGKKRREA CCCEEEECCCCCCEE | 65.60 | - | |
60 | Acetylation | RGDTVLLKGKKRREA CCCEEEECCCCCCEE | 65.60 | 19335618 | |
60 | Sumoylation | RGDTVLLKGKKRREA CCCEEEECCCCCCEE | 65.60 | - | |
60 | Ubiquitination | RGDTVLLKGKKRREA CCCEEEECCCCCCEE | 65.60 | - | |
62 | Sumoylation | DTVLLKGKKRREAVC CEEEECCCCCCEEEE | 41.33 | - | |
62 | Acetylation | DTVLLKGKKRREAVC CEEEECCCCCCEEEE | 41.33 | 19335618 | |
62 | Sumoylation | DTVLLKGKKRREAVC CEEEECCCCCCEEEE | 41.33 | - | |
63 | Sumoylation | TVLLKGKKRREAVCI EEEECCCCCCEEEEE | 66.41 | - | |
63 | Sumoylation | TVLLKGKKRREAVCI EEEECCCCCCEEEEE | 66.41 | - | |
63 | Ubiquitination | TVLLKGKKRREAVCI EEEECCCCCCEEEEE | 66.41 | - | |
73 | Phosphorylation | EAVCIVLSDDTCSDE EEEEEEEECCCCCHH | 23.65 | 22817900 | |
76 | Phosphorylation | CIVLSDDTCSDEKIR EEEEECCCCCHHHHC | 20.92 | 28270605 | |
78 | Phosphorylation | VLSDDTCSDEKIRMN EEECCCCCHHHHCHH | 51.39 | 28270605 | |
81 | Acetylation | DDTCSDEKIRMNRVV CCCCCHHHHCHHHHH | 40.37 | 19335618 | |
81 | Ubiquitination | DDTCSDEKIRMNRVV CCCCCHHHHCHHHHH | 40.37 | 21906983 | |
101 | Phosphorylation | VRLGDVISIQPCPDV EECCCEEEEEECCCC | 18.28 | 22817900 | |
105 | S-nitrosocysteine | DVISIQPCPDVKYGK CEEEEEECCCCCCCC | 2.29 | - | |
105 | Glutathionylation | DVISIQPCPDVKYGK CEEEEEECCCCCCCC | 2.29 | 22555962 | |
105 | S-nitrosylation | DVISIQPCPDVKYGK CEEEEEECCCCCCCC | 2.29 | 22178444 | |
109 | 2-Hydroxyisobutyrylation | IQPCPDVKYGKRIHV EEECCCCCCCCEEEE | 56.52 | - | |
109 | Acetylation | IQPCPDVKYGKRIHV EEECCCCCCCCEEEE | 56.52 | 25953088 | |
109 | Ubiquitination | IQPCPDVKYGKRIHV EEECCCCCCCCEEEE | 56.52 | 21890473 | |
110 | Phosphorylation | QPCPDVKYGKRIHVL EECCCCCCCCEEEEE | 27.94 | 22817900 | |
112 | Acetylation | CPDVKYGKRIHVLPI CCCCCCCCEEEEEEC | 45.12 | 25953088 | |
112 | Ubiquitination | CPDVKYGKRIHVLPI CCCCCCCCEEEEEEC | 45.12 | - | |
136 | Sumoylation | NLFEVYLKPYFLEAY CEEEEEECHHHHHHH | 21.71 | - | |
136 | Sumoylation | NLFEVYLKPYFLEAY CEEEEEECHHHHHHH | 21.71 | - | |
138 | Phosphorylation | FEVYLKPYFLEAYRP EEEEECHHHHHHHCC | 21.14 | 22817900 | |
143 | Phosphorylation | KPYFLEAYRPIRKGD CHHHHHHHCCCCCCC | 13.93 | 22817900 | |
148 | Malonylation | EAYRPIRKGDIFLVR HHHCCCCCCCEEEEE | 62.75 | 26320211 | |
148 | Ubiquitination | EAYRPIRKGDIFLVR HHHCCCCCCCEEEEE | 62.75 | - | |
155 | Methylation | KGDIFLVRGGMRAVE CCCEEEEECCCCEEE | 37.79 | 115919777 | |
164 | Sumoylation | GMRAVEFKVVETDPS CCCEEEEEEEECCCC | 31.68 | - | |
164 | Acetylation | GMRAVEFKVVETDPS CCCEEEEEEEECCCC | 31.68 | 19335618 | |
164 | Sumoylation | GMRAVEFKVVETDPS CCCEEEEEEEECCCC | 31.68 | - | |
164 | Ubiquitination | GMRAVEFKVVETDPS CCCEEEEEEEECCCC | 31.68 | 21890473 | |
168 | Phosphorylation | VEFKVVETDPSPYCI EEEEEEECCCCCCEE | 41.42 | 28152594 | |
171 | Phosphorylation | KVVETDPSPYCIVAP EEEECCCCCCEEECC | 31.17 | 28152594 | |
173 | Phosphorylation | VETDPSPYCIVAPDT EECCCCCCEEECCCE | 10.11 | 28152594 | |
180 | Phosphorylation | YCIVAPDTVIHCEGE CEEECCCEEEEECCC | 21.94 | 28152594 | |
190 | 2-Hydroxyisobutyrylation | HCEGEPIKREDEEES EECCCCCCCCCCHHH | 61.52 | - | |
190 | Acetylation | HCEGEPIKREDEEES EECCCCCCCCCCHHH | 61.52 | 26051181 | |
190 | Ubiquitination | HCEGEPIKREDEEES EECCCCCCCCCCHHH | 61.52 | - | |
197 | Phosphorylation | KREDEEESLNEVGYD CCCCCHHHHHHCCCC | 39.51 | 25159151 | |
203 | Phosphorylation | ESLNEVGYDDIGGCR HHHHHCCCCCCCHHH | 18.67 | 21406692 | |
211 | 2-Hydroxyisobutyrylation | DDIGGCRKQLAQIKE CCCCHHHHHHHHHHH | 54.46 | - | |
211 | Ubiquitination | DDIGGCRKQLAQIKE CCCCHHHHHHHHHHH | 54.46 | 21890473 | |
217 | Ubiquitination | RKQLAQIKEMVELPL HHHHHHHHHHHHCCC | 27.90 | 21906983 | |
219 | Sulfoxidation | QLAQIKEMVELPLRH HHHHHHHHHHCCCCC | 2.11 | 30846556 | |
231 | Acetylation | LRHPALFKAIGVKPP CCCHHHHHHCCCCCC | 39.69 | 26051181 | |
231 | Methylation | LRHPALFKAIGVKPP CCCHHHHHHCCCCCC | 39.69 | 24604063 | |
231 | Ubiquitination | LRHPALFKAIGVKPP CCCHHHHHHCCCCCC | 39.69 | 21890473 | |
236 | Ubiquitination | LFKAIGVKPPRGILL HHHHCCCCCCCEEEE | 44.05 | 21906983 | |
244 | Phosphorylation | PPRGILLYGPPGTGK CCCEEEEECCCCCCH | 24.92 | 25147952 | |
249 | Phosphorylation | LLYGPPGTGKTLIAR EEECCCCCCHHHHHH | 41.08 | 22817900 | |
251 | 2-Hydroxyisobutyrylation | YGPPGTGKTLIARAV ECCCCCCHHHHHHHH | 39.74 | - | |
251 | Acetylation | YGPPGTGKTLIARAV ECCCCCCHHHHHHHH | 39.74 | 19335618 | |
251 | Ubiquitination | YGPPGTGKTLIARAV ECCCCCCHHHHHHHH | 39.74 | 21890473 | |
252 | Phosphorylation | GPPGTGKTLIARAVA CCCCCCHHHHHHHHH | 25.41 | 28348404 | |
276 | Phosphorylation | INGPEIMSKLAGESE EECHHHHHHHCCCCH | 30.13 | 22817900 | |
277 | Ubiquitination | NGPEIMSKLAGESES ECHHHHHHHCCCCHH | 25.61 | - | |
282 | Phosphorylation | MSKLAGESESNLRKA HHHHCCCCHHHHHHH | 45.46 | 25159151 | |
284 | Phosphorylation | KLAGESESNLRKAFE HHCCCCHHHHHHHHH | 50.90 | 25159151 | |
288 | 2-Hydroxyisobutyrylation | ESESNLRKAFEEAEK CCHHHHHHHHHHHHH | 61.67 | - | |
288 | Ubiquitination | ESESNLRKAFEEAEK CCHHHHHHHHHHHHH | 61.67 | 21906983 | |
295 | Ubiquitination | KAFEEAEKNAPAIIF HHHHHHHHCCCEEEE | 66.51 | 21906983 | |
312 | Acetylation | ELDAIAPKREKTHGE CHHHHCCCCCCCCHH | 65.25 | 134165 | |
312 | Ubiquitination | ELDAIAPKREKTHGE CHHHHCCCCCCCCHH | 65.25 | 21890473 | |
315 | "N6,N6,N6-trimethyllysine" | AIAPKREKTHGEVER HHCCCCCCCCHHHHH | 50.26 | - | |
315 | Acetylation | AIAPKREKTHGEVER HHCCCCCCCCHHHHH | 50.26 | 19335618 | |
315 | Methylation | AIAPKREKTHGEVER HHCCCCCCCCHHHHH | 50.26 | 23349634 | |
316 | Phosphorylation | IAPKREKTHGEVERR HCCCCCCCCHHHHHH | 30.29 | 22817900 | |
326 | Phosphorylation | EVERRIVSQLLTLMD HHHHHHHHHHHHHHH | 16.85 | 23403867 | |
330 | Phosphorylation | RIVSQLLTLMDGLKQ HHHHHHHHHHHHHHH | 28.73 | 22817900 | |
332 | Sulfoxidation | VSQLLTLMDGLKQRA HHHHHHHHHHHHHCC | 3.02 | 30846556 | |
336 | Acetylation | LTLMDGLKQRAHVIV HHHHHHHHHCCEEEE | 43.18 | 19335618 | |
336 | Ubiquitination | LTLMDGLKQRAHVIV HHHHHHHHHCCEEEE | 43.18 | 21890473 | |
344 | Sulfoxidation | QRAHVIVMAATNRPN HCCEEEEEEECCCCC | 1.12 | 30846556 | |
347 | Phosphorylation | HVIVMAATNRPNSID EEEEEEECCCCCCCC | 23.40 | 29214152 | |
352 | Phosphorylation | AATNRPNSIDPALRR EECCCCCCCCHHHHH | 30.93 | 19335618 | |
375 | Phosphorylation | DIGIPDATGRLEILQ CCCCCCCCCCEEEEE | 30.16 | 22817900 | |
385 | Phosphorylation | LEILQIHTKNMKLAD EEEEEEECCCCEECC | 26.24 | 21406692 | |
386 | Acetylation | EILQIHTKNMKLADD EEEEEECCCCEECCC | 40.66 | 19335618 | |
386 | Ubiquitination | EILQIHTKNMKLADD EEEEEECCCCEECCC | 40.66 | 21890473 | |
389 | Ubiquitination | QIHTKNMKLADDVDL EEECCCCEECCCCCH | 50.33 | - | |
403 | Phosphorylation | LEQVANETHGHVGAD HHHHHHHCCCCHHHH | 32.72 | - | |
425 | Ubiquitination | AALQAIRKKMDLIDL HHHHHHHHHCCCCCC | 46.46 | - | |
436 | Phosphorylation | LIDLEDETIDAEVMN CCCCCCCCCCHHHHH | 36.16 | 17192257 | |
457 | Phosphorylation | DDFRWALSQSNPSAL HHHHHHHHCCCHHHH | 24.66 | 22817900 | |
459 | Phosphorylation | FRWALSQSNPSALRE HHHHHHCCCHHHHHH | 47.54 | 22817900 | |
462 | Phosphorylation | ALSQSNPSALRETVV HHHCCCHHHHHHHEE | 44.16 | 21712546 | |
486 | 2-Hydroxyisobutyrylation | IGGLEDVKRELQELV CCCHHHHHHHHHHHH | 53.10 | - | |
486 | Ubiquitination | IGGLEDVKRELQELV CCCHHHHHHHHHHHH | 53.10 | 20639865 | |
495 | Phosphorylation | ELQELVQYPVEHPDK HHHHHHCCCCCCCCC | 11.19 | 28152594 | |
502 | 2-Hydroxyisobutyrylation | YPVEHPDKFLKFGMT CCCCCCCCCCCCCCC | 57.98 | - | |
502 | Acetylation | YPVEHPDKFLKFGMT CCCCCCCCCCCCCCC | 57.98 | 25953088 | |
502 | Ubiquitination | YPVEHPDKFLKFGMT CCCCCCCCCCCCCCC | 57.98 | 21890473 | |
505 | 2-Hydroxyisobutyrylation | EHPDKFLKFGMTPSK CCCCCCCCCCCCCCC | 42.90 | - | |
505 | Acetylation | EHPDKFLKFGMTPSK CCCCCCCCCCCCCCC | 42.90 | 19335618 | |
505 | Ubiquitination | EHPDKFLKFGMTPSK CCCCCCCCCCCCCCC | 42.90 | 21906983 | |
509 | Phosphorylation | KFLKFGMTPSKGVLF CCCCCCCCCCCCEEE | 25.45 | 21712546 | |
511 | Phosphorylation | LKFGMTPSKGVLFYG CCCCCCCCCCEEEEC | 32.64 | 21712546 | |
512 | Acetylation | KFGMTPSKGVLFYGP CCCCCCCCCEEEECC | 55.00 | 19335618 | |
512 | Ubiquitination | KFGMTPSKGVLFYGP CCCCCCCCCEEEECC | 55.00 | 21906983 | |
517 | Phosphorylation | PSKGVLFYGPPGCGK CCCCEEEECCCCCCH | 25.26 | 28152594 | |
522 | S-nitrosylation | LFYGPPGCGKTLLAK EEECCCCCCHHHHHH | 6.61 | 22178444 | |
522 | S-palmitoylation | LFYGPPGCGKTLLAK EEECCCCCCHHHHHH | 6.61 | 29575903 | |
524 | 2-Hydroxyisobutyrylation | YGPPGCGKTLLAKAI ECCCCCCHHHHHHHH | 39.82 | - | |
524 | Acetylation | YGPPGCGKTLLAKAI ECCCCCCHHHHHHHH | 39.82 | 19335618 | |
524 | Ubiquitination | YGPPGCGKTLLAKAI ECCCCCCHHHHHHHH | 39.82 | 21890473 | |
525 | Phosphorylation | GPPGCGKTLLAKAIA CCCCCCHHHHHHHHH | 16.58 | 23312004 | |
529 | Acetylation | CGKTLLAKAIANECQ CCHHHHHHHHHHHHH | 40.05 | 19335618 | |
529 | Ubiquitination | CGKTLLAKAIANECQ CCHHHHHHHHHHHHH | 40.05 | 21906983 | |
535 | S-nitrosocysteine | AKAIANECQANFISI HHHHHHHHHCCEEEE | 4.67 | - | |
535 | S-nitrosylation | AKAIANECQANFISI HHHHHHHHHCCEEEE | 4.67 | 19483679 | |
541 | Phosphorylation | ECQANFISIKGPELL HHHCCEEEEECHHHH | 17.70 | 22817900 | |
543 | Ubiquitination | QANFISIKGPELLTM HCCEEEEECHHHHEE | 62.72 | - | |
555 | Phosphorylation | LTMWFGESEANVREI HEEECCCCCHHHHHH | 42.25 | 22817900 | |
565 | Ubiquitination | NVREIFDKARQAAPC HHHHHHHHHHHHCCE | 34.42 | 21890473 | |
572 | S-nitrosocysteine | KARQAAPCVLFFDEL HHHHHCCEEEEECCH | 3.40 | - | |
572 | Glutathionylation | KARQAAPCVLFFDEL HHHHHCCEEEEECCH | 3.40 | 22555962 | |
572 | S-nitrosylation | KARQAAPCVLFFDEL HHHHHCCEEEEECCH | 3.40 | 19483679 | |
581 | Phosphorylation | LFFDELDSIAKARGG EEECCHHHHHHHCCC | 36.75 | 25338102 | |
584 | Ubiquitination | DELDSIAKARGGNIG CCHHHHHHHCCCCCC | 36.63 | 21906983 | |
586 | Methylation | LDSIAKARGGNIGDG HHHHHHHCCCCCCCC | 53.50 | 115919781 | |
599 | Methylation | DGGGAADRVINQILT CCCHHHHHHHHHHHH | 26.87 | 115919785 | |
606 | Phosphorylation | RVINQILTEMDGMST HHHHHHHHHCCCCCC | 30.78 | 21406692 | |
608 | Sulfoxidation | INQILTEMDGMSTKK HHHHHHHCCCCCCCC | 4.55 | 21406390 | |
612 | Phosphorylation | LTEMDGMSTKKNVFI HHHCCCCCCCCCEEE | 42.47 | 20068231 | |
613 | Phosphorylation | TEMDGMSTKKNVFII HHCCCCCCCCCEEEE | 36.83 | 20068231 | |
614 | 2-Hydroxyisobutyrylation | EMDGMSTKKNVFIIG HCCCCCCCCCEEEEE | 34.74 | - | |
614 | Acetylation | EMDGMSTKKNVFIIG HCCCCCCCCCEEEEE | 34.74 | 19335618 | |
614 | Ubiquitination | EMDGMSTKKNVFIIG HCCCCCCCCCEEEEE | 34.74 | 21906983 | |
615 | Acetylation | MDGMSTKKNVFIIGA CCCCCCCCCEEEEEC | 59.43 | 19335618 | |
615 | Ubiquitination | MDGMSTKKNVFIIGA CCCCCCCCCEEEEEC | 59.43 | - | |
623 | Phosphorylation | NVFIIGATNRPDIID CEEEEECCCCCCCCC | 26.92 | 22817900 | |
644 | Nitration | GRLDQLIYIPLPDEK CCCCEEEEEECCCHH | 12.70 | - | |
644 | Phosphorylation | GRLDQLIYIPLPDEK CCCCEEEEEECCCHH | 12.70 | 17360941 | |
651 | Acetylation | YIPLPDEKSRVAILK EEECCCHHHHEEHHH | 51.44 | 23954790 | |
651 | Ubiquitination | YIPLPDEKSRVAILK EEECCCHHHHEEHHH | 51.44 | 21890473 | |
652 | Phosphorylation | IPLPDEKSRVAILKA EECCCHHHHEEHHHH | 29.91 | 22817900 | |
658 | 2-Hydroxyisobutyrylation | KSRVAILKANLRKSP HHHEEHHHHHCCCCC | 29.17 | - | |
658 | Acetylation | KSRVAILKANLRKSP HHHEEHHHHHCCCCC | 29.17 | 27178108 | |
658 | Malonylation | KSRVAILKANLRKSP HHHEEHHHHHCCCCC | 29.17 | 26320211 | |
658 | Ubiquitination | KSRVAILKANLRKSP HHHEEHHHHHCCCCC | 29.17 | 21890473 | |
663 | Acetylation | ILKANLRKSPVAKDV HHHHHCCCCCCCCCC | 63.38 | 19335618 | |
663 | Ubiquitination | ILKANLRKSPVAKDV HHHHHCCCCCCCCCC | 63.38 | 21906983 | |
664 | Phosphorylation | LKANLRKSPVAKDVD HHHHCCCCCCCCCCC | 20.41 | 22817900 | |
668 | Acetylation | LRKSPVAKDVDLEFL CCCCCCCCCCCHHHH | 59.52 | 23236377 | |
668 | Malonylation | LRKSPVAKDVDLEFL CCCCCCCCCCCHHHH | 59.52 | 26320211 | |
668 | Succinylation | LRKSPVAKDVDLEFL CCCCCCCCCCCHHHH | 59.52 | - | |
668 | Succinylation | LRKSPVAKDVDLEFL CCCCCCCCCCCHHHH | 59.52 | - | |
668 | Sumoylation | LRKSPVAKDVDLEFL CCCCCCCCCCCHHHH | 59.52 | - | |
668 | Ubiquitination | LRKSPVAKDVDLEFL CCCCCCCCCCCHHHH | 59.52 | 21890473 | |
677 | Acetylation | VDLEFLAKMTNGFSG CCHHHHHHHCCCCCC | 48.69 | 19335618 | |
677 | Ubiquitination | VDLEFLAKMTNGFSG CCHHHHHHHCCCCCC | 48.69 | - | |
679 | Phosphorylation | LEFLAKMTNGFSGAD HHHHHHHCCCCCCCC | 31.33 | 22817900 | |
683 | Phosphorylation | AKMTNGFSGADLTEI HHHCCCCCCCCHHHH | 34.17 | 22817900 | |
688 | Phosphorylation | GFSGADLTEICQRAC CCCCCCHHHHHHHHH | 24.69 | 22817900 | |
691 | S-palmitoylation | GADLTEICQRACKLA CCCHHHHHHHHHHHH | 1.50 | 26865113 | |
696 | Acetylation | EICQRACKLAIRESI HHHHHHHHHHHHHHH | 39.71 | 19335618 | |
696 | Ubiquitination | EICQRACKLAIRESI HHHHHHHHHHHHHHH | 39.71 | 21890473 | |
702 | Phosphorylation | CKLAIRESIESEIRR HHHHHHHHHHHHHHH | 23.08 | 30266825 | |
705 | Phosphorylation | AIRESIESEIRRERE HHHHHHHHHHHHHHH | 36.33 | 22617229 | |
708 | Methylation | ESIESEIRRERERQT HHHHHHHHHHHHHCC | 30.29 | 115919789 | |
715 | Phosphorylation | RRERERQTNPSAMEV HHHHHHCCCCCCCCC | 56.15 | 29214152 | |
718 | Phosphorylation | RERQTNPSAMEVEED HHHCCCCCCCCCCCC | 42.17 | 29507054 | |
720 | Sulfoxidation | RQTNPSAMEVEEDDP HCCCCCCCCCCCCCC | 7.51 | 21406390 | |
746 | Phosphorylation | AMRFARRSVSDNDIR HHHHHHHCCCHHHHH | 22.03 | 19335618 | |
748 | Phosphorylation | RFARRSVSDNDIRKY HHHHHCCCHHHHHHH | 31.76 | 19335618 | |
753 | Methylation | SVSDNDIRKYEMFAQ CCCHHHHHHHHHHHH | 38.06 | 115919793 | |
754 | 2-Hydroxyisobutyrylation | VSDNDIRKYEMFAQT CCHHHHHHHHHHHHH | 45.99 | - | |
754 | Acetylation | VSDNDIRKYEMFAQT CCHHHHHHHHHHHHH | 45.99 | 19335618 | |
754 | Malonylation | VSDNDIRKYEMFAQT CCHHHHHHHHHHHHH | 45.99 | 26320211 | |
754 | Ubiquitination | VSDNDIRKYEMFAQT CCHHHHHHHHHHHHH | 45.99 | 21890473 | |
755 | Phosphorylation | SDNDIRKYEMFAQTL CHHHHHHHHHHHHHH | 11.63 | 22817900 | |
757 | Sulfoxidation | NDIRKYEMFAQTLQQ HHHHHHHHHHHHHHH | 2.83 | 28465586 | |
761 | Phosphorylation | KYEMFAQTLQQSRGF HHHHHHHHHHHHCCC | 24.09 | 22817900 | |
765 | Phosphorylation | FAQTLQQSRGFGSFR HHHHHHHHCCCCCEE | 22.78 | 30108239 | |
770 | Phosphorylation | QQSRGFGSFRFPSGN HHHCCCCCEECCCCC | 15.81 | 28102081 | |
775 | Phosphorylation | FGSFRFPSGNQGGAG CCCEECCCCCCCCCC | 47.89 | 24043423 | |
784 | Phosphorylation | NQGGAGPSQGSGGGT CCCCCCCCCCCCCCC | 46.38 | 17525332 | |
787 | Phosphorylation | GAGPSQGSGGGTGGS CCCCCCCCCCCCCCC | 26.99 | 24043423 | |
791 | Phosphorylation | SQGSGGGTGGSVYTE CCCCCCCCCCCCCCC | 41.46 | 24043423 | |
794 | Phosphorylation | SGGGTGGSVYTEDND CCCCCCCCCCCCCCC | 17.19 | 24043423 | |
796 | Phosphorylation | GGTGGSVYTEDNDDD CCCCCCCCCCCCCCC | 13.20 | 28102081 | |
797 | Phosphorylation | GTGGSVYTEDNDDDL CCCCCCCCCCCCCCC | 34.41 | 28796482 | |
805 | Phosphorylation | EDNDDDLYG------ CCCCCCCCC------ | 27.99 | 19605366 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
326 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
352 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
352 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
509 | T | Phosphorylation | Kinase | CDK4 | P11802 | PSP |
664 | S | Phosphorylation | Kinase | CDK4 | P11802 | PSP |
746 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
746 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
748 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
748 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
784 | S | Phosphorylation | Kinase | ATR | Q13535 | PSP |
784 | S | Phosphorylation | Kinase | PRKDC | P78527 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | TRIM13 | O60858 | PMID:22199232 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TERA_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
167320 | Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) | |||||
613954 | Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia (ALS14) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-770 AND SER-775, ANDMASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-37; SER-282;SER-284; SER-457; SER-746 AND SER-748, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; THR-436; THR-509 ANDSER-787, AND MASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-702 AND SER-705, ANDMASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-784, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-805, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of HeLa cells using stable isotope labelingwith amino acids in cell culture (SILAC)."; Amanchy R., Kalume D.E., Iwahori A., Zhong J., Pandey A.; J. Proteome Res. 4:1661-1671(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-805, AND MASSSPECTROMETRY. |